Stocktoria
Liquidia Corp LQDA
Nasdaq · stock · Pharmaceutical Preparations · website · IPO 2018-07-26
Liquidia Corp statistics & valuation
Market cap$7.0B
P / S43.9×
Net margin-43.5%
Return on equity-154.0%
FCF margin-25.3%
Return on capital-26.7%
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else from the latest financial reports.
Profitability & efficiency
Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Operating margin | -32.5% | -866.6% | -419.6% | -243.3% | -263.0% | -7989.0% | -580.1% |
| Net margin | -43.5% | -916.6% | -448.9% | -257.4% | -269.0% | -8080.1% | -589.5% |
| FCF margin | -25.3% | -702.9% | -245.0% | -183.1% | -265.6% | -7422.2% | -621.1% |
| Return on assets | -21.0% | -55.7% | -66.3% | -31.7% | -36.9% | -60.0% | -69.1% |
| Return on equity | -154.0% | -161.6% | -166.0% | -45.4% | -53.0% | -84.1% | -136.2% |
| Debt / equity | — | — | — | 0.22× | 0.16× | 0.14× | 0.29× |
| Current ratio | 2.01 | 4.43 | 4.85 | 11.34 | 8.36 | 5.63 | 3.34 |
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.